logo
Urgent food warning issued over Whole Foods product that may contain E.coli

Urgent food warning issued over Whole Foods product that may contain E.coli

Independent2 days ago

US agriculture officials have issued a public health alert, warning that ground beef sold at Whole Foods stores across the nation may be contaminated with potentially dangerous E. coli bacteria.
The alert applies to 1-pound, vacuum-packed packages of Organic Rancher beef, produced on May 22 and May 23 by NPC Processing Inc., of Shelburne, Vermont. The products have use-by dates of June 19 and June 20.
The US Food Safety and Inspection Service (FSIS) has not requested a recall because the products are no longer available for purchase. However, the FSIS has warned that the meat may still be in consumers ' refrigerators or freezers.
The meat was produced in Australia or Uruguay and processed in the US. It was then sent to distributors in Connecticut, Georgia, Illinois and Maryland before being shipped to Whole Foods stores nationwide.
The issue was discovered after company officials notified the FSIS that they had shipped beef products that tested positive for E. coli O157, a type of bacteria that can cause serious illness.
Officials stated that no illnesses linked to the product have been reported so far. Consumers who have the product should throw it away or return it to the store.
E. coli bacteria can cause infections with symptoms that include dehydration, diarrhea and cramps.
Most people recover within a week, but some people can become severely ill and develop a dangerous kidney condition. Children under age 5 and older adults are most at risk.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Blood test for Alzheimer's disease is highly accurate, researchers say
Blood test for Alzheimer's disease is highly accurate, researchers say

Sky News

time2 hours ago

  • Sky News

Blood test for Alzheimer's disease is highly accurate, researchers say

Researchers say a new blood test for Alzheimer's disease has been shown to be highly accurate in detecting people with early symptoms. Scientists looked for two proteins - amyloid beta 42/40 and p-tau217 - and found the test was 95% accurate in identifying patients with existing cognitive impairment linked to the condition. The US study involved 509 patients in an outpatient memory clinic in Florida and was published in the medical journal Alzheimer's and Dementia. The test, which has already been approved by the US regulator, was also 82% accurate for specificity, which means it could rule out people without dementia. Dr Gregg Day, who led the study, said the test was as good as existing, but more invasive, tests. He said the next step was to extend the test to a wider range of patients, including those with early Alzheimer's who do not have any cognitive symptoms. Scientists say the two proteins, which they have identified in blood plasma, are associated with the buildup of amyloid plaques. Amyloid protein can be found in our brains, but in Alzheimer's disease, amyloid sticks together and forms abnormal deposits, which are thought to be toxic to brain cells. Dr Richard Oakley, associate director for research and innovation at the Alzheimer's Society in the UK, said the results "suggest this test is very accurate". "Blood tests will be critical to accelerate diagnosis and give more people access to the care, support and treatments they desperately need faster than ever before," he added. In the UK, the Blood Biomarker Challenge is a multi-million-pound research programme supported by the Alzheimer's Society, Alzheimer's Research UK and the National Institute for Health and Care Research. 1:09 Its goal is to bring blood tests for dementia diagnosis to the NHS by 2029. Dr Julia Dudley, head of research at Alzheimer's Research UK, said: "We urgently need to improve how we diagnose dementia and it's great to see international research working towards this goal." She said the studies like the Blood Biomarker Challenge are a "crucial part of making diagnosis easier and faster, which will bring us closer to a cure". "The study is testing blood tests, including p-tau217, in thousands of people from sites across the UK," she added.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store